News

Find News

Filter articles

Applied Filters

Showing 71 to 80 of 127 results

Report predicts generic drugs will soar by 2020

International15-06-2016

The “Global Generic Drugs Market 2016-2020” report predicts that the expiry of patents for branded drugs, worth $150 billion, will allow generic companies to prosper by 2020.

Sequenom targets Ariosa in Australia

Australia08-06-2016

Sequenom has filed a patent infringement lawsuit against Sonic Healthcare, Australian Clinical Labs and Ariosa Diagnostics at the Australian Federal Court.

BIO 2016: Understanding innovation is key to success

International07-06-2016

For something to be innovative it must “add value” and companies must ensure they understand the term in order to succeed, the 2016 BIO International Convention has heard.

‘2016 State of Innovation Report’: Biotech innovation decreases by 2%

International16-05-2016

Biotech was the only technology area out of 12 studied that has shown a global decline in its year-on-year innovation, declining by 2%, according to the “2016 State of Innovation Report: Disruptive, Game-Changing Innovation” by Thomson Reuters.

Gilead gets Sovaldi patent approval in India despite opposition

India10-05-2016

Gilead has been granted a patent for its hepatitis C drug Sovaldi in India, despite concerns over the cost of the drug.

Australia criticised over ‘excessive’ protection for pharma patents

Australia04-05-2016

Australia’s patent system is “poorly targeted” and protection for pharmaceutical inventions is “excessive”, according to a government advisory committee.

Syringes delivered to GSK doors in pneumonia vaccine row

28-04-2016

Advocate group Médecins Sans Frontières delivered a suitcase full of syringes to the London headquarters of pharmaceutical company GSK in protest at the price of a pneumonia vaccine.

US top, India bottom in biopharma innovation report

International11-04-2016

The US has been ranked as the country that contributes most to global biopharmaceutical innovation through the use of its policies.

GSK to widen access to medicines in world’s poorest countries

International01-04-2016

Pharmaceutical company GSK has adopted a new approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.

Teva announces global re-brand

International29-02-2016

Pharmaceutical company Teva is set to re-brand itself as part of its plan to build “a new breed of healthcare company”.

Showing 71 to 80 of 127 results

LSIPR